摘要
目的:探究血清IL-35介导的炎症反应及可能的免疫逃逸在前列腺癌发生的临床应用。方法:选取2016年1月~2017年12月我院收治的前列腺患者64例,其中前列腺增生31例(前列腺增生组),前列腺癌33例(前列腺癌组)。同时采取Gleason评分对前列腺癌患者进行分组(≥7分组和<7分组)。检测所有患者血清IL-35水平,同时评估IL-10和IL-6水平及免疫系统指标(CD4^+/CD8^+)变化。结果:前列腺癌组患者血清IL-35、IL-10及IL-6水平高于前列腺增生组,外周血CD4^+/CD8^+水平低于前列腺增生组(P<0.05);此外,IL-35、IL-10、IL-6水平及CD4^+/CD8^+与PSA、Gleason评分呈正相关性(P<0.05)。结论:前列腺癌组患者的血清IL-10、IL-6水平及CD4^+/CD8^+与前列腺增生组比较差异有统计学意义(P<0.05),可能与IL-35介导的炎症反应及免疫逃逸存在一定的相关性,可见IL-35在临床评估前列腺癌患者病情方面有重要的潜在应用价值。
Objective:To investigate the clinical application of serum IL-35 mediated inflammatory response and immune escape in the development of prostate cancer.Method:Sixty-four cases with prostate disease in our hospital were selected from January 2016 to December 2017.There were 31 cases of benign prostatic hyperplasia and 33 cases of prostate cancer.Prostate cancer patients were grouped by Gleason score(≥7 group;<7 group).Serum IL-35 level was measured in all patients.IL-10 and IL-6 levels and immune system parameters(CD4^+/CD8^+)were also assessed.Result:The levels of serum IL-35,IL-10 and IL-6 in cases with adenocarcinoma were higher than those in benign prostatic hyperplasia group.The level of CD4^+/CD8^+in peripheral blood was lower than that in benign prostatic hyperplasia group(P<0.05).In addition,IL-35,IL-10,IL-6 and CD4^+/CD8^+were positively correlated with PSA and Gleason scores(P<0.05).Conclusion:Serum levels of IL-10,IL-6 and CD4^+/CD8^+in cases with prostate cancer are different from those with benign prostatic hyperplasia,which may be related to IL-35-mediated inflammatory reaction and immune escape.IL-35 shows important application values in the condition of cases with prostate cancer.
作者
王鹏桥
谢喜
杨雷
李峰
李伟
陈胜龙
WANG Pengqiao;XIE Xi;YANG Lei;LI Feng;LI Wei;CHEN Shenglong(Department of Urology,First Affiliated Hospital of Chengdu Medical College,Chengdu,610500,China)
出处
《临床泌尿外科杂志》
2020年第3期176-179,共4页
Journal of Clinical Urology
关键词
前列腺癌
炎性因子
免疫逃逸
临床应用
IL-35
prostate cancer
inflammatory factors
immune escape
clinical application
IL-35
